➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Baxter
Mallinckrodt
Moodys
AstraZeneca

Last Updated: July 6, 2020

DrugPatentWatch Database Preview

SYMADINE Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Symadine patents expire, and when can generic versions of Symadine launch?

Symadine is a drug marketed by Solvay and is included in one NDA.

The generic ingredient in SYMADINE is amantadine hydrochloride. There are seven drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the amantadine hydrochloride profile page.

Summary for SYMADINE
Drug patent expirations by year for SYMADINE
Recent Clinical Trials for SYMADINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Columbia UniversityPhase 4
Edward Hines Jr. VA HospitalN/A

See all SYMADINE clinical trials

US Patents and Regulatory Information for SYMADINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Solvay SYMADINE amantadine hydrochloride CAPSULE;ORAL 071000-001 Sep 4, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Baxter
Mallinckrodt
Moodys
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.